(18)F-FLT PET/CT Adds Value to (18)F-FDG PET/CT for Diagnosing Relapse After Definitive Radiotherapy in Patients with Lung Cancer: Results of a Prospective Clinical Trial

Diagnosing relapse after radiotherapy for lung cancer is challenging. The specificity of both CT and (18)F-FDG PET/CT is low because of radiation-induced changes. 3′-deoxy-3′-(18)F-fluorothymidine ((18)F-FLT) PET has previously demonstrated higher specificity for malignancy than (18)F-FDG PET. We in...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Nucl Med
Huvudupphovsmän: Christensen, Tine Nøhr, Langer, Seppo W., Persson, Gitte, Larsen, Klaus Richter, Loft, Annika, Amtoft, Annemarie Gjelstrup, Berthelsen, Anne Kiil, Johannesen, Helle Hjorth, Keller, Sune Høgild, Kjaer, Andreas, Fischer, Barbara Malene
Materialtyp: Artigo
Språk:Inglês
Publicerad: Society of Nuclear Medicine 2021
Ämnen:
Clinical Investigation
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7611370/
https://ncbi.nlm.nih.gov/pubmed/33037090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.120.247742
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk